Nebenwirkungen · Repatha
Repatha 140 mg solution for injection in pre-filled syringe Repatha 140 mg solution for injection in pre-filled pen Repatha 420 mg solution for injection in cartridge · Abschnitt 4.8 · PDF-Seite 6
HOS-131151 · Präparat HOS-097013
MedDRA system organ class Adverse reactions Frequency category (SOC) Infections and infestations Influenza Common Nasopharyngitis Common Upper respiratory tract Common infection Immune system disorders Hypersensitivity Common Rash Common Urticaria Uncommon Nervous system disorders Headache Common Gastrointestinal disorders Nausea Common Skin and subcutaneous tissue Angioedema Rare disorders Musculoskeletal and connective Back pain Common tissue disorders Arthralgia Common Myalgia Common General disorders and Injection site reactions1 Common administration site conditions Influenza-like illness Uncommon 1 See section Description of selected adverse reactions.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-04T12:30:00Z · SHA-256 d2505aa52199753458c8b299a339c2c3d9d330c34201edb39c0bf49997f26fba · Passage 63d585773d72df7494c93c01a0b8adc1ca857fedb3dee9c75119fb17aa4b82ef · Zeichen 912–2273 im Abschnitt